/AFIB
AFIB Stock - Acutus Medical, Inc.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+1499900.0%upside
Target: $1.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AFIB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$1.50
STOP LOSS$0.00
RISK/REWARD1:14999.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-1.31
52W High$0.08
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $20.16M | $7.16M | $3.03M | $17.26M | $8.46M |
| Gross Profit | $1.01M | $-3,137,000 | $-1,910,000 | $-15,662,000 | $-7,425,000 |
| Gross Margin | 5.0% | -43.8% | -63.0% | -90.7% | -87.7% |
| Operating Income | $-57,000 | $-14,361,000 | $-22,972,000 | $-115,868,000 | $-91,333,000 |
| Net Income | $-9,547,000 | $-81,663,000 | $-39,616,000 | $-117,683,000 | $-101,981,000 |
| Net Margin | -47.4% | -1139.9% | -1307.0% | -681.7% | -1204.9% |
| EPS | $-0.32 | $-2.81 | $-1.39 | $-4.11 | $-8.94 |
Company Overview
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AFIBBeat Rate
53%
Last 15 quarters
Avg Surprise
-196.0%
EPS vs Estimate
Beats / Misses
8/7
Last 12 quarters
Latest EPS
$-0.05
Q1 2025
EPS Surprise History
Q2 23
+13.6%
$-0.57vs$-0.66
Q3 23
-3.3%
$-0.63vs$-0.61
Q4 23
+21.1%
$-0.45vs$-0.57
Q2 24
-193.1%
$-1.15vs$-0.39
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Apr 3, 2025 | — | — | — | — |
Q1 2025 | Mar 24, 2025 | — | $-0.05 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.03 | — | — |
Q3 2024 | Aug 8, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 9, 2024 | — | $-0.07 | — | — |
Q2 2024 | Apr 1, 2024 | $-0.39 | $-1.15 | -193.1% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $-0.57 | $-0.45 | +21.1% | ✓ BEAT |
Q3 2023 | Aug 7, 2023 | $-0.61 | $-0.63 | -3.3% | ✗ MISS |
Q2 2023 | May 11, 2023 | $-0.66 | $-0.57 | +13.6% | ✓ BEAT |
Q1 2023 | Mar 16, 2023 | $-0.71 | $0.41 | +157.7% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $-0.83 | $-0.72 | +13.3% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-0.83 | $0.16 | +119.3% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $-0.99 | $-1.00 | -1.0% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | $-0.92 | $-1.00 | -8.7% | ✗ MISS |
Q4 2021 | Nov 11, 2021 | $-0.92 | $-0.87 | +5.4% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-1.00 | $-0.89 | +11.0% | ✓ BEAT |
Q2 2021 | May 12, 2021 | $-0.70 | $-0.97 | -38.6% | ✗ MISS |
Q1 2021 | Mar 18, 2021 | $-0.71 | $-0.89 | -25.4% | ✗ MISS |
Q4 2020 | Nov 12, 2020 | $-1.11 | $-0.91 | +18.0% | ✓ BEAT |
Q3 2020 | Sep 17, 2020 | $-1.03 | $-32.24 | -3030.1% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about AFIB
What is AFIB's current stock price?
Acutus Medical, Inc. (AFIB) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for AFIB?
The average analyst price target for AFIB is $1.50, based on 1 analyst.
What sector is Acutus Medical, Inc. in?
Acutus Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is AFIB's market cap?
Acutus Medical, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AFIB pay dividends?
No, Acutus Medical, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARDS
Aridis Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
CGHC
Capital Group Holdings, Inc.
$0.00
Mkt Cap: $0.0B
EVLO
Evelo Biosciences, Inc.
$0.00
Mkt Cap: $0.0B
ICCT
iCoreConnect Inc.
$0.00
Mkt Cap: $0.0B
IGNT
Ingen Technologies, Inc.
$0.00
Mkt Cap: $0.0B
INFIQ
Infinity Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
LFPI
LifePoint, Inc.
$0.00
Mkt Cap: $0.0B
SWNM
Southwestern Medical Solutions, Inc.
$0.00
Mkt Cap: $0.0B
TCLIF
Theraclion S.A.
$0.00
Mkt Cap: $0.0B
WPHM
Winston Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to AFIB for comparison